• BioLizard is now an Official Illumina Connected Analytics Implementation Partner

    Monday September 5th 2022

  • Nieuwe investering voor HERAN Partners: Aspect Analytics

    Monday September 5th 2022

  • Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology

    Friday September 2nd 2022

  • Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software

    Tuesday May 31st 2022

  • Digital histopathology company launches integrated platform capable of accelerating drug development

    Tuesday April 26th 2022

  • Kantify announces its new breakthrough AI technology for drug discovery

    Thursday March 31st 2022

  • Pathomation announces new COO and expands its leadership team

    Friday February 18th 2022

  • Pre-existing immune cells can predict early response to hepatitis B vaccine

    Tuesday January 25th 2022

  • Your news here?

  • KU Leuven kiest met Open Data-aanpak resoluut voor Open Wetenschap

    Thursday January 20th 2022

  • Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

    Wednesday September 29th 2021

  • Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

    Thursday September 9th 2021


Strategic Partners